ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q2Scopus Q1SCImago #3,299Gold OA

ACS Bio & Med Chem Au

Acronym:acs
•
Abbreviation (ISO):ACS BIO MED CHEM AU
•
Identifier (ISSN):2694-2437(Print)
•
Publisher:American Chemical Society
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
3.5↓ -0.8
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for ACS Bio & Med Chem Au

WoS Q2
0246020233.820244.320253.52026
Annual Impact Factor Metric
Current (2026):3.5
Scopus SJR & RankScopus Q1
1.267
#3,299

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
21

21 papers with at least that number of citations each

WoS: ESCIQ2
Self-Citation Rate2.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
0articles/year
100% Gold OA•0% Original Research

Aims & Scope

ACS Bio &Med Chem Au是开放获取期刊,发表生物和药物化学各个方面的短文、综合文章、评论和观点。欢迎提供基本见解或描述新颖合成的研究,以及临床或其它基于应用的工作。期刊收稿范围包括对生命所有领域的生物或细胞功能的化学、物理、机械和/或结构基础的实验和理论研究。它涵盖了化学生物学、合成生物学、疾病生物学、细胞生物学、农业和食品、天然产物研究、核酸生物学、神经科学、结构生物学和生物物理学等领域。 期刊收录研究方向: 药物化学,包括化合物设计和优化,生物学评估,药物递送和药物递送系统的分子机理理解,成像剂以及小生物活性分子和大生物活性分子的药理学和转化科学 用于鉴定(或结构 - 活性关系分析)生物活性分子,配体及其靶标的新型计算,化学信息学和结构研究 应用已建立的计算方法的计算研究,但只能与新颖和原始的实验数据相结合(例如,在设计和测试新化合物的情况下) 与传染病相关的文章 病原体,宿主 - 病原体相互作用,治疗,诊断,疫苗,药物输送系统以及与传染病有关的其他生物医学技术开发 ACS Bio & Med Chem Au is a broad scope, open access journal, which publishes short letters, comprehensive articles, reviews, and perspectives in all aspects of biological and medicinal chemistry. Studies providing fundamental insights or describing novel syntheses, as well as clinical or other applications-based work, are welcomed. This broad scope includes experimental and theoretical studies on the chemical, physical, mechanistic, and/or structural basis of biological or cell function in all domains of life. It encompasses the fields of chemical biology, synthetic biology, disease biology, cell biology, agriculture and food, natural products research, nucleic acid biology, neuroscience, structural biology, and biophysics. The journal publishes studies that pertain to a broad range of medicinal chemistry, including compound design and optimization, biological evaluation, molecular mechanistic understanding of drug delivery and drug delivery systems, imaging agents, and pharmacology and translational science of both small and large bioactive molecules. Novel computational, cheminformatics, and structural studies for the identification (or structure-activity relationship analysis) of bioactive molecules, ligands, and their targets, are also welcome. The journal will consider computational studies applying established computational methods, but only in combination with novel and original experimental data (e.g., in cases where new compounds have been designed and tested). Also included in the scope of the journal are articles relating to infectious diseases research on pathogens, host-pathogen interactions, therapeutics, diagnostics, vaccines, drug-delivery systems, and other biomedical technology development pertaining to infectious diseases.

Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q2
Rank163/328
IndexESCI
JCRESCI2026

CHEMISTRY, MEDICINAL

Q2
Rank36/72
IndexESCI
JCIESCI2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q2
Rank126/328
IndexESCI
JCIESCI2026

CHEMISTRY, MEDICINAL

Q2
Rank31/72
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

4 year
2026Latest
IF3.5
Articles / Year—
Total Citations—
2025
IF4.3
Articles / Year—
Total Citations—
2024
IF3.8
Articles / Year—
Total Citations—
2023
IF0
Articles / Year—
Total Citations—

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,299Scopus Q1SCImago Profile
Scopus Coverage:2021-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.267

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
4.15

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,310 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations605
3-Year Documents130
Citable Documents126

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate37.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

BiochemistryQ1
Drug DiscoveryQ1
Pharmaceutical ScienceQ1
Molecular BiologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
2区BIOCHEMISTRY & MOLECULAR BIOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

ACS Bio & Med Chem Au (acronym: acs, abbr: ACS BIO MED CHEM AU, ISSN: 2694-2437) is a peer-reviewed international scholarly journal in the field of Pharmacology, published by American Chemical Society in United States since 2021. The periodical holds a Journal Impact Factor (JIF) of 3.50, ranking in quartile Q2 of Web of Science (ESCI), a Scopus SJR indicator of 1.267 (Q1), an H-index of 21.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 0 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,310 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
American Chemical Society
Publication Language
English
Frequency
Bimonthly
Founding Year
2021
Indexing & Databases
ScopusPubMed
Editorial Address
AMER CHEMICAL SOC, 1155 16TH ST, NW, WASHINGTON, USA, DC, 20036

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 3dc1431e-ad42-4c3c-8620-0c00ef1f0570
Database Updated: 2026-09-28